Neuland Labs.

{
  "main_header": {
    "sid": 229993,
    "name": "Neuland Labs.",
    "stock_name": "Neuland Labs.",
    "full_name": "Neuland Laboratories Ltd",
    "name_url": "stocks-analysis/neuland-labs",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "12,918.00",
    "chg": -42,
    "chgp": "-0.32%",
    "dir": -1,
    "prev_price": "12,960.00",
    "mcapval": "16,573.65 Cr",
    "mcap": "Small Cap",
    "scripcode": 524558,
    "symbol": "NEULANDLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE794A01010",
    "curr_date": "Feb 13",
    "curr_time": "",
    "bse_nse_vol": "12.86 k",
    "exc_status": "Active",
    "traded_date": "Feb 13, 2026",
    "traded_date_str": "2026 02 13",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/neuland-labs-229993-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Neuland Laboratories Ltd Faces Mildly Bearish Technical Shift Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-faces-mildly-bearish-technical-shift-amid-market-volatility-3836443",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NeulandLaborato_technicaldot_3836443.png",
        "date": "2026-02-13 08:00:53",
        "description": "Neuland Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance as of early February 2026. Despite a recent downgrade in price performance, the stock’s technical indicators present a complex picture, with some signals suggesting caution while others hint at potential resilience in the near term."
      },
      {
        "title": "Are Neuland Laboratories Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-neuland-laboratories-ltd-latest-results-good-or-bad-3831471",
        "imagepath": "",
        "date": "2026-02-10 19:24:45",
        "description": "Neuland Laboratories Ltd's latest financial results for Q3 FY26 reflect a complex operational landscape marked by significant challenges. The company reported a net profit of ₹40.57 crores, which represents a notable decline of 60.06% year-on-year and a sequential drop of 58.11%. This sharp decrease in profitability raises concerns about the sustainability of earnings amidst rising operational costs and margin pressures.\n\nOn the revenue front, Neuland Laboratories achieved ₹439.71 crores, indicating a modest year-on-year growth of 10.47%. However, this figure also reflects a sequential decline of 14.50% from the previous quarter, highlighting volatility in order flows typical of the contract development and manufacturing organization (CDMO) business model. The operating margin, which stood at 17.54%, has compressed significantly compared to both the prior year and the previous quarter, indicating substantia..."
      },
      {
        "title": "Neuland Laboratories Ltd Opens with Significant Gap Down Amid Market Concerns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-opens-with-significant-gap-down-amid-market-concerns-3831136",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NeulandLaborato_gapdown_3831136.png",
        "date": "2026-02-10 11:45:21",
        "description": "Neuland Laboratories Ltd witnessed a sharp gap down at the opening of trade on 10 Feb 2026, reflecting heightened market concerns following recent developments. The stock opened with a loss of 6.75%, underperforming its sector and broader market indices, signalling a cautious sentiment among traders."
      },
      {
        "title": "Neuland Laboratories Ltd Sees Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-sees-technical-momentum-shift-amid-mixed-market-signals-3829543",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NeulandLaborato_technicaldot_3829543.png",
        "date": "2026-02-10 08:00:59",
        "description": "Neuland Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend, supported by recent price gains and evolving indicator signals. Despite mixed readings from key technical tools such as MACD, RSI, and moving averages, the stock’s recent performance suggests cautious optimism for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Why is Neuland Laboratories Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-neuland-laboratories-ltd-fallingrising-3829305",
        "imagepath": "",
        "date": "2026-02-10 00:13:02",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Neuland Laboratories opened the trading session with a gap up of 3.02%, signalling strong buying momentum from the outset. Throughout the day, the stock reached an intraday high of ₹14,162.05, representing an 8.64% increase from the previous close. This performance notably outpaced the broader sector, with the stock outperforming its peers by 4.95% on the day. Such a rebound after a short spell of declines suggests that investors are regaining confidence in the company’s prospects.</p>\n<p>Despite this strong daily performance, the stock’s year-to-date return remains negative at -8.58%, underperforming the Sensex’s modest decline of -1.36% over the same period. Over the past month, Neuland Laboratories has also seen a 6.02% decrease, co..."
      },
      {
        "title": "Neuland Laboratories Q3 FY26: Profit Plunges 60% YoY Despite Revenue Growth",
        "link": "https://www.marketsmojo.com/news/result-analysis/neuland-laboratories-q3-fy26-profit-plunges-60-yoy-despite-revenue-growth-3829154",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NeulandLaborato_quaterlyResult_3829154.png",
        "date": "2026-02-09 20:31:03",
        "description": "Neuland Laboratories Ltd., a Hyderabad-based pharmaceutical manufacturer specialising in bulk drugs and active pharmaceutical ingredients, reported a steep decline in profitability for Q3 FY26, with consolidated net profit plummeting 60.06% year-on-year to ₹40.57 crores despite revenue growth of 10.47%. The results, which saw the stock surge 6.53% to ₹13,886.95 following the announcement, reveal a company grappling with margin compression and operational challenges even as it maintains revenue momentum. With a market capitalisation of ₹16,998 crores, the small-cap pharmaceutical player faces critical questions about sustainability of its premium valuation amid deteriorating profitability metrics."
      },
      {
        "title": "Neuland Laboratories Ltd Hits Intraday High with 8.29% Surge on 9 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-hits-intraday-high-with-829-surge-on-9-feb-2026-3828916",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NeulandLaborato_priceRelatedfactors_3828916.png",
        "date": "2026-02-09 15:15:54",
        "description": "Neuland Laboratories Ltd recorded a robust intraday performance on 09 Feb 2026, surging to a day’s high of Rs 14,138.15, marking an 8.45% increase. This sharp rise outpaced the Pharmaceuticals & Biotechnology sector and the broader market, reflecting notable trading momentum and a positive reversal after two days of declines."
      },
      {
        "title": "Neuland Laboratories Downgraded to Sell Amid Technical Weakness and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-downgraded-to-sell-amid-technical-weakness-and-valuation-concerns-3827988",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NeulandLaborato_mojoScore_3827988.png",
        "date": "2026-02-09 08:06:47",
        "description": "Neuland Laboratories Ltd has seen its investment rating downgraded from Hold to Sell as of 6 February 2026, reflecting a combination of deteriorating technical indicators, expensive valuation metrics, and subdued long-term financial growth despite recent quarterly improvements. The company’s stock performance continues to lag behind broader market indices, prompting a reassessment of its investment appeal."
      },
      {
        "title": "Neuland Laboratories Declines 1.56% Despite Hold Upgrade: 5 Key Factors Shaping the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-declines-156-despite-hold-upgrade-5-key-factors-shaping-the-week-3827412",
        "imagepath": "",
        "date": "2026-02-08 12:01:11",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> Rating upgraded to Hold as technicals improve and financials strengthen</p>\n                    <p><strong>3 Feb:</strong> Significant gap up opening, outperforming Sensex and sector</p>\n                    <p><strong>3 Feb:</strong> Technical momentum shifts amid mixed market signals</p>\n                    <p><strong>5 Feb:</strong> Technical trend moves from mildly bearish to sideways consolidation</p>\n                    <p><strong>6 Feb:</strong> Mildly bearish technical shift amid mixed momentum; week closes lower</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</d..."
      }
    ],
    "total": 735,
    "sid": "229993",
    "stock_news_url": "https://www.marketsmojo.com/news/neuland-laboratories-229993"
  },
  "announcements": [
    {
      "details": "Neuland Laboratories Limited has informed the Exchange regarding the Registrar & Share Transfer Agent Update- Change in name of Registrar & Share Transfer Agent of the Company.",
      "source": "NSE",
      "caption": "Neuland Laboratories Limited - Registrar & Share Transfer Agent Update",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "Neuland Laboratories Limited has submitted to the Exchange a copy of half yearly disclosure on Related Party Transactions pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Neuland Laboratories Limited - Other General Purpose",
      "datetime": "27-Nov-2019"
    },
    {
      "details": "Neuland Laboratories Limited has informed the Exchange regarding a press release dated November 14, 2019, titled \"Press Release\".",
      "source": "NSE",
      "caption": "Neuland Laboratories Limited - Press Release",
      "datetime": "15-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Neuland Laboratories Ltd has declared <strong>120%</strong> dividend, ex-date: 18 Jul 25",
          "dt": "2025-07-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Neuland Laboratories Ltd has announced <strong>4:25</strong> rights issue, ex-date: 13 Aug 14",
          "dt": "2014-08-13",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Neuland Laboratories Ltd Faces Mildly Bearish Technical Shift Amid Market Volatility

2026-02-13 08:00:53

Neuland Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance as of early February 2026. Despite a recent downgrade in price performance, the stock’s technical indicators present a complex picture, with some signals suggesting caution while others hint at potential resilience in the near term.

Read full news article

Are Neuland Laboratories Ltd latest results good or bad?

2026-02-10 19:24:45

Neuland Laboratories Ltd's latest financial results for Q3 FY26 reflect a complex operational landscape marked by significant challenges. The company reported a net profit of ₹40.57 crores, which represents a notable decline of 60.06% year-on-year and a sequential drop of 58.11%. This sharp decrease in profitability raises concerns about the sustainability of earnings amidst rising operational costs and margin pressures. On the revenue front, Neuland Laboratories achieved ₹439.71 crores, indicating a modest year-on-year growth of 10.47%. However, this figure also reflects a sequential decline of 14.50% from the previous quarter, highlighting volatility in order flows typical of the contract development and manufacturing organization (CDMO) business model. The operating margin, which stood at 17.54%, has compressed significantly compared to both the prior year and the previous quarter, indicating substantia...

Read full news article

Neuland Laboratories Ltd Opens with Significant Gap Down Amid Market Concerns

2026-02-10 11:45:21

Neuland Laboratories Ltd witnessed a sharp gap down at the opening of trade on 10 Feb 2026, reflecting heightened market concerns following recent developments. The stock opened with a loss of 6.75%, underperforming its sector and broader market indices, signalling a cautious sentiment among traders.

Read full news article

Neuland Laboratories Ltd Sees Technical Momentum Shift Amid Mixed Market Signals

2026-02-10 08:00:59

Neuland Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend, supported by recent price gains and evolving indicator signals. Despite mixed readings from key technical tools such as MACD, RSI, and moving averages, the stock’s recent performance suggests cautious optimism for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Why is Neuland Laboratories Ltd falling/rising?

2026-02-10 00:13:02

Recent Price Movement and Market Context

Neuland Laboratories opened the trading session with a gap up of 3.02%, signalling strong buying momentum from the outset. Throughout the day, the stock reached an intraday high of ₹14,162.05, representing an 8.64% increase from the previous close. This performance notably outpaced the broader sector, with the stock outperforming its peers by 4.95% on the day. Such a rebound after a short spell of declines suggests that investors are regaining confidence in the company’s prospects.

Despite this strong daily performance, the stock’s year-to-date return remains negative at -8.58%, underperforming the Sensex’s modest decline of -1.36% over the same period. Over the past month, Neuland Laboratories has also seen a 6.02% decrease, co...

Read full news article

Neuland Laboratories Q3 FY26: Profit Plunges 60% YoY Despite Revenue Growth

2026-02-09 20:31:03

Neuland Laboratories Ltd., a Hyderabad-based pharmaceutical manufacturer specialising in bulk drugs and active pharmaceutical ingredients, reported a steep decline in profitability for Q3 FY26, with consolidated net profit plummeting 60.06% year-on-year to ₹40.57 crores despite revenue growth of 10.47%. The results, which saw the stock surge 6.53% to ₹13,886.95 following the announcement, reveal a company grappling with margin compression and operational challenges even as it maintains revenue momentum. With a market capitalisation of ₹16,998 crores, the small-cap pharmaceutical player faces critical questions about sustainability of its premium valuation amid deteriorating profitability metrics.

Read full news article

Neuland Laboratories Ltd Hits Intraday High with 8.29% Surge on 9 Feb 2026

2026-02-09 15:15:54

Neuland Laboratories Ltd recorded a robust intraday performance on 09 Feb 2026, surging to a day’s high of Rs 14,138.15, marking an 8.45% increase. This sharp rise outpaced the Pharmaceuticals & Biotechnology sector and the broader market, reflecting notable trading momentum and a positive reversal after two days of declines.

Read full news article

Neuland Laboratories Downgraded to Sell Amid Technical Weakness and Valuation Concerns

2026-02-09 08:06:47

Neuland Laboratories Ltd has seen its investment rating downgraded from Hold to Sell as of 6 February 2026, reflecting a combination of deteriorating technical indicators, expensive valuation metrics, and subdued long-term financial growth despite recent quarterly improvements. The company’s stock performance continues to lag behind broader market indices, prompting a reassessment of its investment appeal.

Read full news article

Neuland Laboratories Declines 1.56% Despite Hold Upgrade: 5 Key Factors Shaping the Week

2026-02-08 12:01:11

Key Events This Week

2 Feb: Rating upgraded to Hold as technicals improve and financials strengthen

3 Feb: Significant gap up opening, outperforming Sensex and sector

3 Feb: Technical momentum shifts amid mixed market signals

5 Feb: Technical trend moves from mildly bearish to sideways consolidation

6 Feb: Mildly bearish technical shift amid mixed momentum; week closes lower

Week OpenRead full news article

View All News